Evidence for polymorphic oxidation of sparteine in Japanese subjects.
Open Access
- 1 April 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 23 (4), 482-485
- https://doi.org/10.1111/j.1365-2125.1987.tb03080.x
Abstract
The metabolism of sparteine which exhibits a genetic polymorphism in Caucasians was studied in 84 unrelated Japanese subjects. In contrast to a recent study where debrisoquine was used as a probe and no poor metabolizers could be observed in Japanese involving 100 subjects, two subjects had a urinary metabolic ratio of sparteine greater than 20 and thus were poor metabolizers of sparteine. The incidence of poor metabolizer phenotype of sparteine oxidation of 2% seems to be lower in Japanese as compared with various Caucasian populations where 5 to 10% are poor metabolizers of sparteine. However, this is not conclusive, because the 95% confidence interval of the observed frequency, 0.6 to 8%, covers the range reported in the literature for Caucasians.This publication has 15 references indexed in Scilit:
- Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in GhanaiansClinical Pharmacology & Therapeutics, 1985
- Inter-ethnic difference in sparteine oxidation among Ghanaians and GermansEuropean Journal of Clinical Pharmacology, 1985
- Polymorphic drug oxidation in humans.1984
- The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions.Journal of Medical Genetics, 1983
- Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entitiesClinical Pharmacology & Therapeutics, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Sparteine metabolism in Canadian CaucasiansClinical Pharmacology & Therapeutics, 1981
- Deficient metabolism of debrisoquine and sparteineClinical Pharmacology & Therapeutics, 1980
- Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquineEuropean Journal of Clinical Pharmacology, 1980
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979